Biden ex­ec­u­tive or­der lifts ban on us­ing march-in rights to low­er drug costs

As part of an ex­ec­u­tive or­der is­sued last Fri­day mar­ket­ed as pro­mot­ing eco­nom­ic com­pe­ti­tion, Pres­i­dent Joe Biden di­rect­ed the gov­ern­ment to pause a pro­posed rule from the Trump ad­min­is­tra­tion that would have pre­vent­ed the use of so-called “march-in rights,” which have nev­er been used be­fore but hy­po­thet­i­cal­ly could low­er pre­scrip­tion drug costs.

For­mer Pres­i­dent Don­ald Trump in­tro­duced the po­ten­tial ban as part of a swath of reg­u­la­to­ry agen­da items en­act­ed ear­li­er this year as he pre­pared to leave of­fice. Biden had left the pro­pos­al in place un­til Fri­day, mark­ing a re­ver­sal from just last month when the White House out­lined its own reg­u­la­to­ry plans and in­clud­ed the Trump rule.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER